(Q33389158)

26 July 2017

title

Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia (English)

1 reference

26 July 2017

0 references

1 reference

4

John M Kane

1 reference

26 July 2017

3

Carol Tamminga

1 reference

26 July 2017

Daniel E Casey

1

1 reference

26 July 2017

David G Daniel

2

1 reference

26 July 2017

Tram Tran-Johnson

5

1 reference

26 July 2017

Patricia Wozniak

6

1 reference

26 July 2017

Walid Abi-Saab

7

1 reference

26 July 2017

Jeff Baker

8

1 reference

26 July 2017

Laura Redden

9

1 reference

26 July 2017

Nicholas Greco

10

1 reference

26 July 2017

Mario Saltarelli

11

1 reference

26 July 2017

language of work or name

English

0 references

publication date

3 December 2008

1 reference

26 July 2017

published in

Neuropsychopharmacology

1 reference

26 July 2017

volume

34

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

1330-1338

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2008.209

26 July 2017

exact match

0 references

cites work

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

A study of the safety, efficacy, and tolerability of switching from the standard delayed release preparation of divalproex sodium to the extended release formulation in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

Cortical inhibitory neurons and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

Management of the negative symptoms of schizophrenia: new treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

GABA and Schizophrenia: A Review of Basic Science and Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

Emerging principles of altered neural circuitry in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

7 January 2021

inferred from DOI database lookup

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

7 January 2021

inferred from DOI database lookup

Augmentation of risperidone with valproic acid

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.209

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NPP.2008.209

1 reference

Dimensions Publication ID

26 July 2017

1032979726

0 references

Fatcat ID

release_dtj2bprv5na5lahmphyhg7g3fy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dtj2bprv5na5lahmphyhg7g3fy

24 November 2022

mapped directly with Wikidata item

1 reference